Literature DB >> 15908172

Myelotoxicity of trichothecenes and apoptosis: an in vitro study on human cord blood CD34+ hematopoietic progenitor.

G Le Dréan1, M Auffret, P Batina, F Arnold, Y Sibiril, D Arzur, D Parent-Massin.   

Abstract

Previous studies have revealed that hematological disorders associated with trichothecenes intoxication in humans could result from hematopoiesis inhibition. The most frequent and potent trichothecene mycotoxins are T-2 toxin and deoxynivalenol (DON), respectively. Apoptosis induction by these two toxins was investigated in vitro on human hematopoietic progenitors (CD34+ cells). Hoechst coloration, DNA fragmentation and annexin-V/PI labeling in flow cytometry showed that T-2 toxin, in contrast to DON, induced apoptosis in CD34+ cells. T-2 toxin effect was dose- and time-dependent with a significant increase of apoptotic cells as early as 3h after incubation at 10(-7) M and a maximum reached at 12 h. This observation evidenced the high sensitivity of hematopoietic progenitors to T-2 toxin. The inhibition of T-2 toxin-induced apoptosis by a pan-caspase inhibitor (Z-VAD-fmk) suggested the involvement of caspases. The proportional increase of caspase-3 specific activity (DEVDase) with T-2 toxin concentration confirmed its role in the process. After incubation of CD34+ cells with T-2 toxin, in conditions that induced apoptosis, clonal expansion of granulo-monocytes, erythrocytes and megakaryocytes precursors was dose-dependently inhibited. The hematological effects observed in T-2 toxin mycotoxicosis could then be assigned to hematopoiesis inhibition by apoptosis. Different mechanisms that need to be further elucidated are involved in DON myelotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908172     DOI: 10.1016/j.tiv.2005.03.017

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

1.  In silico prediction of drug-induced myelotoxicity by using Naïve Bayes method.

Authors:  Hui Zhang; Peng Yu; Teng-Guo Zhang; Yan-Li Kang; Xiao Zhao; Yuan-Yuan Li; Jia-Hui He; Ji Zhang
Journal:  Mol Divers       Date:  2015-07-11       Impact factor: 2.943

Review 2.  Mechanisms of deoxynivalenol-induced gene expression and apoptosis.

Authors:  J J Pestka
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2008-09

3.  Modulation of innate and antigen-specific immune functions directed against Listeria monocytogenes by fungal toxins in vitro.

Authors:  I Herter; G Geginat; H Hof; C Kupfahl
Journal:  Mycotoxin Res       Date:  2014-02-14       Impact factor: 3.833

4.  Protective effects of antioxidants on deoxynivalenol-induced damage in murine lymphoma cells.

Authors:  Alois Strasser; Mirja Carra; Khaled Ghareeb; Wageha Awad; Josef Böhm
Journal:  Mycotoxin Res       Date:  2013-06-28       Impact factor: 3.833

5.  The fungal T-2 toxin alters the activation of primary macrophages induced by TLR-agonists resulting in a decrease of the inflammatory response in the pig.

Authors:  Julie Seeboth; Romain Solinhac; Isabelle P Oswald; Laurence Guzylack-Piriou
Journal:  Vet Res       Date:  2012-04-24       Impact factor: 3.683

Review 6.  Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae.

Authors:  James J Pestka
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

7.  Optimization of the QuEChERS-Based Analytical Method for Investigation of 11 Mycotoxin Residues in Feed Ingredients and Compound Feeds.

Authors:  Hyungju Seo; Sunyeong Jang; Hyeongwook Jo; Haejin Kim; Seunghwa Lee; Hyejeong Yun; Minhee Jeong; Joonkwan Moon; Taewoong Na; Hyunjeong Cho
Journal:  Toxins (Basel)       Date:  2021-10-29       Impact factor: 4.546

8.  The Protective Effect of Heme Oxygenase-1 on Liver Injury Caused by DON-Induced Oxidative Stress and Cytotoxicity.

Authors:  Zitong Meng; Liangliang Wang; Yuxiao Liao; Zhao Peng; Dan Li; Xiaolei Zhou; Shuang Liu; Yanmei Li; Andreas K Nüssler; Liegang Liu; Liping Hao; Wei Yang
Journal:  Toxins (Basel)       Date:  2021-10-17       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.